Ana
Vega Gliemmo
University of Cologne
Colonia, AlemaniaPublicacións en colaboración con investigadores/as de University of Cologne (8)
2020
-
Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
JAMA Oncology, Vol. 6, Núm. 8, pp. 1218-1230
2019
-
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
npj Breast Cancer, Vol. 5, Núm. 1
2018
-
A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk
Cancer Research, Vol. 78, Núm. 18, pp. 5419-5430
2017
-
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Nature Genetics, Vol. 49, Núm. 12, pp. 1767-1778
2016
-
Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples
Journal of Medical Genetics, Vol. 53, Núm. 8, pp. 548-558
2014
-
Comparison of mRNA splicing assay protocols across multiple laboratories: Recommendations for best practice in standardized clinical testing
Clinical Chemistry, Vol. 60, Núm. 2, pp. 341-352
-
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: A report from the ENIGMA consortium
Human Molecular Genetics, Vol. 23, Núm. 14, pp. 3666-3680
2009
-
Association of ESR1 gene tagging SNPs with breast cancer risk
Human Molecular Genetics, Vol. 18, Núm. 6, pp. 1131-1139